AEMD — Aethlon Medical Balance Sheet
0.000.00%
Annual balance sheet for Aethlon Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 17.1 | 14.5 | 5.44 | 5.5 | 5.03 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.128 | 0 | — | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 18.2 | 15.1 | 6.23 | 5.95 | 5.57 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.14 | 2.3 | 1.9 | 1.28 | 0.665 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 19.4 | 17.5 | 8.25 | 7.36 | 6.33 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.82 | 1.51 | 1.83 | 1.9 | 1.45 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.28 | 2.44 | 2.48 | 2.24 | 1.45 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.1 | 15.1 | 5.77 | 5.12 | 4.89 |
| Total Liabilities & Shareholders' Equity | 19.4 | 17.5 | 8.25 | 7.36 | 6.33 |
| Total Common Shares Outstanding |